{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:41:00Z","timestamp":1795034460732,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of Chongqing, China","award":["cstc2019jcyj-msxm0314 of Yishu Tang"],"award-info":[{"award-number":["cstc2019jcyj-msxm0314 of Yishu Tang"]}]},{"name":"National Natural Science Foundation of Chongqing, China","award":["cstc2019jcyj-msxm0314 of Yishu Tang"],"award-info":[{"award-number":["cstc2019jcyj-msxm0314 of Yishu Tang"]}]},{"name":"National Natural Science Foundation of Chongqing, China","award":["cstc2019jcyj-msxm0314 of Yishu Tang"],"award-info":[{"award-number":["cstc2019jcyj-msxm0314 of Yishu Tang"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81501818 of Yishu Tang"],"award-info":[{"award-number":["81501818 of Yishu Tang"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81501818 of Yishu Tang"],"award-info":[{"award-number":["81501818 of Yishu Tang"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81501818 of Yishu Tang"],"award-info":[{"award-number":["81501818 of Yishu Tang"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11128-6","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:52:33Z","timestamp":1748317953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["HPV genotype distribution and cervical lesions in Chongqing: a comprehensive analysis of 229,770 females (2015\u20122023)"],"prefix":"10.1186","volume":"25","author":[{"given":"Hongli","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"11128_CR1","unstructured":"IARC. GLOBOCAN 2022: Cancer Today. Lyon: IARC; 2024 [cited 2025 May 11]. Available from: [https:\/\/gco.iarc.fr\/today]"},{"issue":"2","key":"11128_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/s2214-109x(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203. https:\/\/doi.org\/10.1016\/s2214-109x(19)30482-6.","journal-title":"Lancet Glob Health"},{"key":"11128_CR3","doi-asserted-by":"publisher","first-page":"1332696","DOI":"10.3389\/fpubh.2024.1332696","volume":"12","author":"X Yao","year":"2024","unstructured":"Yao X, Li Q, Chen Y, et al. Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023. Front Public Health. 2024;12:1332696. https:\/\/doi.org\/10.3389\/fpubh.2024.1332696.","journal-title":"Front Public Health"},{"issue":"9","key":"11128_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1136\/jcp.2004.022863","volume":"58","author":"KS Cuschieri","year":"2005","unstructured":"Cuschieri KS, Cubie HA, Whitley MW, et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol. 2005;58(9):946\u201350. https:\/\/doi.org\/10.1136\/jcp.2004.022863.","journal-title":"J Clin Pathol"},{"issue":"9446","key":"11128_CR5","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/s0140-6736(04)17354-6","volume":"364","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Shiboski S, Hills NK, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004;364(9446):1678\u201383. https:\/\/doi.org\/10.1016\/s0140-6736(04)17354-6.","journal-title":"Lancet"},{"key":"11128_CR6","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd ed. Geneva: WHO. 2021 [cited 2025 May 11]. Available from: [https:\/\/www.who.int\/publications\/i\/item\/9789240030824]"},{"issue":"4","key":"11128_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41416-020-01153-4","volume":"124","author":"M Kamal","year":"2021","unstructured":"Kamal M, Lameiras S, Deloger M, et al. Human papilloma virus (HPV) integration signature in cervical cancer: identification of MACROD2 gene as HPV hot spot integration site. Br J Cancer. 2021;124(4):777\u201385. https:\/\/doi.org\/10.1038\/s41416-020-01153-4.","journal-title":"Br J Cancer"},{"issue":"1","key":"11128_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12985-020-01383-1","volume":"17","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ang Q, Wu H, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China\u2019s top 3 hospital, 2009\u20132019. Virol J. 2020;17(1):104. https:\/\/doi.org\/10.1186\/s12985-020-01383-1.","journal-title":"Virol J"},{"issue":"7","key":"11128_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.7326\/m21-3798","volume":"175","author":"HG Rosenblum","year":"2022","unstructured":"Rosenblum HG, Lewis RM, Gargano JW, et al. Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the united States, 2003 to 2018. Ann Intern Med. 2022;175(7):918\u201326. https:\/\/doi.org\/10.7326\/m21-3798.","journal-title":"Ann Intern Med"},{"issue":"10","key":"11128_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1940-6207.Capr-09-0031","volume":"2","author":"SK Kjaer","year":"2009","unstructured":"Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila). 2009;2(10):868\u201378. https:\/\/doi.org\/10.1158\/1940-6207.Capr-09-0031.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"11128_CR11","doi-asserted-by":"publisher","first-page":"22249","DOI":"10.1038\/s41598-023-48222-1","volume":"13","author":"X Wei","year":"2023","unstructured":"Wei X, Zhang J, Mei Y, et al. Prevalence and genotype distribution of HPV6\/11\/16\/18 infections among 180,276 outpatient females from a women\u2019s and children\u2019s central hospital, 2015\u20132021, Chengdu, China. Sci Rep. 2023;13(1):22249. https:\/\/doi.org\/10.1038\/s41598-023-48222-1.","journal-title":"Sci Rep"},{"issue":"1","key":"11128_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12905-019-0785-3","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Tang D, Wang K, et al. HPV genotype prevalence and distribution during 2009\u20132018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. BMC Womens Health. 2019;19(1):90. https:\/\/doi.org\/10.1186\/s12905-019-0785-3.","journal-title":"BMC Womens Health"},{"issue":"1","key":"11128_CR13","doi-asserted-by":"publisher","first-page":"e2176009","DOI":"10.1080\/22221751.2023.2176009","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Li Y, Tang Y, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infect. 2023;12(1):e2176009. https:\/\/doi.org\/10.1080\/22221751.2023.2176009.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"11128_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jinf.2021.02.017","volume":"82","author":"HL Bao","year":"2021","unstructured":"Bao HL, Jin C, Wang S, et al. Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study. J Infect. 2021;82(4):75\u201383. https:\/\/doi.org\/10.1016\/j.jinf.2021.02.017.","journal-title":"J Infect"},{"key":"11128_CR15","unstructured":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Female Genital Tumours. 5th ed. Lyon, IARC; 2020."},{"issue":"1","key":"11128_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-024-02317-x","volume":"21","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zha T, Wang X, et al. Prevalence and genotype distribution of HPV infections among women in Chengdu,China. Virol J. 2024;21(1):52. https:\/\/doi.org\/10.1186\/s12985-024-02317-x.","journal-title":"Virol J"},{"key":"11128_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12879-015-0998-5","volume":"15","author":"R Wang","year":"2015","unstructured":"Wang R, Guo XL, Wisman GB, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15:257. https:\/\/doi.org\/10.1186\/s12879-015-0998-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11128_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12879-021-06019-5","volume":"21","author":"LP Luo","year":"2021","unstructured":"Luo LP, He P, Liu QT, et al. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012\u20132018: baseline measures prior to mass HPV vaccination. BMC Infect Dis. 2021;21(1):328. https:\/\/doi.org\/10.1186\/s12879-021-06019-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11128_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12985-022-01879-y","volume":"19","author":"X Li","year":"2022","unstructured":"Li X, Xiang F, Dai J, et al. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China. Virol J. 2022;19(1):146. https:\/\/doi.org\/10.1186\/s12985-022-01879-y.","journal-title":"Virol J"},{"issue":"1","key":"11128_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1175-z","volume":"16","author":"C Zhang","year":"2019","unstructured":"Zhang C, Cheng W, Liu Q, et al. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province. Virol J. 2019;16(1):1\u20137. https:\/\/doi.org\/10.1186\/s12985-019-1175-z.","journal-title":"Virol J"},{"issue":"3","key":"11128_CR21","doi-asserted-by":"publisher","first-page":"e0230640","DOI":"10.1371\/journal.pone.0230640","volume":"15","author":"S Hao","year":"2020","unstructured":"Hao S, Wang C, Liu S, et al. HPV genotypic spectrum in Jilin Province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern. PLoS ONE. 2020;15(3):e0230640. https:\/\/doi.org\/10.1371\/journal.pone.0230640.","journal-title":"PLoS ONE"},{"issue":"1","key":"11128_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12985-023-02262-1","volume":"20","author":"S Liu","year":"2023","unstructured":"Liu S, Mei B, Ouyang Y, et al. Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women. Virol J. 2023;20(1):297. https:\/\/doi.org\/10.1186\/s12985-023-02262-1.","journal-title":"Virol J"},{"issue":"1","key":"11128_CR23","doi-asserted-by":"publisher","first-page":"e0210311","DOI":"10.1371\/journal.pone.0210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. PLoS ONE. 2019;14(1):e0210311. https:\/\/doi.org\/10.1371\/journal.pone.0210311.","journal-title":"PLoS ONE"},{"issue":"12","key":"11128_CR24","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3760\/cma.j.cn112338-20200210-00085","volume":"41","author":"Y Wang","year":"2020","unstructured":"Wang Y, Dong X, Zhao XL, et al. [Genotype distribution and behavioral risk factor analysis of human papillomavirus infection among Kazak women in Xinjiang Uygur autonomous Region][J]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(12):2112\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20200210-00085.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"12","key":"11128_CR25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399. https:\/\/doi.org\/10.1086\/657321.","journal-title":"J Infect Dis"},{"issue":"7","key":"11128_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1473-3099(07)70158-5","volume":"7","author":"S de Sanjos\u00e9","year":"2007","unstructured":"de Sanjos\u00e9 S, Diaz M, Castellsagu\u00e9 X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139. https:\/\/doi.org\/10.1016\/s1473-3099(07)70158-5.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"11128_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/v9100267","volume":"9","author":"PE Gravitt","year":"2017","unstructured":"Gravitt PE, Winer RL. Natural history of HPV infection across the lifespan: role of viral latency. Viruses. 2017;9(10):267. https:\/\/doi.org\/10.3390\/v9100267.","journal-title":"Viruses"},{"issue":"4","key":"11128_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.canep.2012.01.009","volume":"36","author":"FH Zhao","year":"2012","unstructured":"Zhao FH, Tiggelaar SM, Hu SY, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol. 2012;36(4):384\u201390. https:\/\/doi.org\/10.1016\/j.canep.2012.01.009.","journal-title":"Cancer Epidemiol"},{"key":"11128_CR29","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3389\/fmicb.2018.02896","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical Cancer. Front Microbiol. 2018;9:2896. https:\/\/doi.org\/10.3389\/fmicb.2018.02896.","journal-title":"Front Microbiol"},{"issue":"1","key":"11128_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12985-023-02221-w","volume":"20","author":"M Zeng","year":"2023","unstructured":"Zeng M, Zhang X, He L, et al. Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022. Virol J. 2023;20(1):254. https:\/\/doi.org\/10.1186\/s12985-023-02221-w.","journal-title":"Virol J"},{"issue":"8","key":"11128_CR31","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1002\/jmv.27034","volume":"93","author":"W Lu","year":"2021","unstructured":"Lu W, Chen T, Yao Y, et al. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010\u20132019. J Med Virol. 2021;93(8):5118\u201325. https:\/\/doi.org\/10.1002\/jmv.27034.","journal-title":"J Med Virol"},{"issue":"11","key":"11128_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.13523\/j.cb.2006054","volume":"40","author":"XJ Feng","year":"2020","unstructured":"Feng XJ, Hou HL, Yu Q, et al. Market analysis and countermeasures of cervical cancer vaccine in China. China Biotechnol. 2020;40(11):96\u2013101. https:\/\/doi.org\/10.13523\/j.cb.2006054. From CNKI.","journal-title":"China Biotechnol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11128-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:02:36Z","timestamp":1748361756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11128-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11128"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11128-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study was a retrospective study and the identities of patients were intentionally anonymized, no individual informed consent was required, so this study was approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (approval number K2024-124-01) and subject informed consent was exempted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"760"}}